Excessive smoking; participation in another study within 30 days before screening; a history of substance dependence; pregnancy or intention to become pregnant within 30 days of completing the study; current breastfeeding; prolactin level of >200 ng/ml at baseline; clinically significant ECG abnormalities; any acute, serious, or unstable medical condition. The gene discussed is PRL; the disease is substance dependence.